Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Ovagen

Glu-Asp-Leu, Liver Bioregulator Peptide

A synthetic tripeptide bioregulator that targets liver and gastrointestinal health, promoting cellular regeneration, detoxification, and anti-fibrotic effects at the epigenetic level.

Quick Stats
Studies 34
Trials 30
Formula C15H25N3O8
Clear All
Utility 3
pubmed 1990

Oocyte production and ovarian steroid concentrations of immature rats in response to some commercial gonadotrophin preparations.

Henderson. K M KM; Weaver. A A; Wards. R L RL; Ball. K K; Lun. S S; Mullin. C C; McNatty. K P KP

In rats, the FSH‑heavy drug Ovagen boosted egg production almost as well as other high‑FSH products, but only when given continuously rather than as a single shot. Adding a little extra LH helped even more, while too much LH hurt the results.

Utility 3
pubmed 1993

Biopotency in vitro and metabolic clearance rates of five pituitary preparations of follicle stimulating hormone.

Phillips. D J DJ; Hudson. N L NL; Lun. S S; Condell. L A LA; McNatty. K P KP

The study compared five commercially available follicle‑stimulating hormone (FSH) products, including Ovagen, and found that they differ a lot in how strong they are in lab tests and how quickly they disappear from the bloodstream. Ovagen was only about half as potent as the reference standard and had a moderate half‑life of about 13 minutes in mice.

Utility 2
pubmed Jun 20, 2005

The effect of melatonin implants during the seasonal anestrus on embryo production after superovulation in aged high-prolificacy Rasa Aragonesa ewes.

Forcada. F F; Abecia. J A JA; Cebrián-Pérez. J A JA; Muiño-Blanco. T T; Valares. J A...

In older, high‑producing sheep, giving melatonin implants in March modestly improved the quality and survival of embryos after hormone‑driven superovulation, especially three months later, but it didn’t consistently boost ovulation itself.

Utility 2
pubmed Nov 28, 2006

The effects of the prostaglandin E analogue Misoprostol and follicle-stimulating hormone on cervical penetrability in ewes during the peri-ovulatory period.

Leethongdee. Sukanya S; Khalid. Muhammad M; Bhatti. Aleem A; Ponglowhapan. Suppawiwat S; Kershaw. Cl...

In sheep, the cervix naturally softens after hormone treatment, reaching its most relaxed state about 72 hours after stopping the treatment. Giving Ovagen (FSH) directly into the cervix 24 hours after stopping the treatment let researchers insert an insemination tube at 54‑60 hours, earlier than the natural peak. Misoprostol worked similarly, and combining both didn’t improve results.

Utility 2
pubmed 2002

Effect of follicular status on superovulatory response in ewes is influenced by presence of corpus luteum at first FSH dose.

Gonzalez-Bulnes. A A; Garcia-Garcia. R M RM; Santiago-Moreno. J J; Lopez-Sebastian. A A; Cocero. M J...

In sheep, giving the FSH drug Ovagen works better at making embryos if the animal already has a corpus luteum (a temporary hormone‑producing structure) when the first FSH dose is given. If a big dominant follicle is present without a corpus luteum, embryo numbers and quality drop sharply.

Utility 2
pubmed Jun 2, 2016

Diastolic orthostatic hypertension and cardiovascular prognosis in type 2 diabetes: a prospective cohort study.

Wijkman. Magnus M; Länne. Toste T; Östgren. Carl Johan CJ; Nystrom. Fredrik H FH

In people with type 2 diabetes, a noticeable rise in diastolic blood pressure when they stand up (at least 10 mmHg) is fairly common and appears to be linked to a lower chance of heart attacks, strokes, or cardiovascular death. Conversely, a big drop in diastolic pressure on standing is tied to signs of stiffer arteries and thicker carotid walls, which are risk factors for heart disease.

Utility 1
pubmed 1993

Use of single or multiple injections of FSH in embryo collection programmes in goats.

Batt. P A PA; Killeen. I D ID; Cameron. A W AW

The study looked at how different ways of giving the hormone FSH (called Ovagen) affect the number of embryos collected from goats. It found that the traditional method of giving several small injections usually gave the most embryos, while some single‑shot combos worked about as well, but high doses could actually lower success. The results are specific to goat breeding and don’t directly translate to human use.

Utility 1
pubmed Mar 1, 1989

Superovulation and embryo recovery in goats treated with Ovagen and Folltropin.

McNatty. K P KP; Hudson. N L NL; Ball. K K; Mason. A A; Simmons. M H MH

In a goat study, the peptide Ovagen was tested against a commercial super‑ovulation drug (Folltropin). Both treatments produced about the same number of ovulated follicles and embryos, and Ovagen showed a slightly higher number of good-quality embryos, though the differences weren’t statistically significant. Ovagen also had fewer abnormal ovarian structures compared to Folltropin.

Utility 1
pubmed Oct 15, 2000

Effects of FSH commercial preparation and follicular status on follicular growth and superovulatory response in Spanish Merino ewes.

Gonzalez-Bulnes. A A; Santiago-Moreno. J J; Cocero. M J MJ; Lopez-Sebastian. A A

In a study on Spanish Merino sheep, two commercial FSH products (FSH‑P and Ovagen) were compared during super‑ovulation. Both gave similar numbers of ovulated follicles, but the FSH‑P product caused more new and medium‑sized follicles and also more follicles that shrank or didn’t ovulate. The overall egg‑release count was the same for both products.

Utility 1
pubmed May 2, 2006

Effects of progestagens on follicular growth and oocyte developmental competence in FSH-treated ewes.

Berlinguer. F F; Gonzalez-Bulnes. A A; Succu. S S; Leoni. G G; Mossa. F F; Bebbere. D D; Ariznavarre...

In a study with sheep, giving a progesterone‑like drug (progestagen) before stimulating the ovaries with FSH (the Ovagen product) didn’t change how many follicles grew, but it lowered estrogen levels, reduced the number of eggs that could be collected, and cut the success of early embryo development. The findings suggest that the progestagen may hurt egg quality when used together with FSH.

pubmed Jul 23, 2015

Validation of microSecure vitrification (μS-VTF) for the effective cryopreservation of human embryos and oocytes.

Schiewe. Mitchel C MC; Zozula. Shane S; Anderson. Robert E RE; Fahy. Gregory M GM

The study describes a new closed‑system method for freezing human embryos and eggs, showing better survival and birth rates than traditional slow‑freezing, but it does not involve the peptide ovagen or any advice useful for biohackers interested in metabolic or performance enhancement.

pubmed Dec 3, 2009

Transvaginal follicular aspiration and embryo development in superstimulated early postpartum beef cows and subsequent fertility after artificial insemination.

Aller. J F JF; Mucci. N C NC; Kaiser. G G GG; Ríos. G G; Callejas. S S SS; Alberio. R H RH

The study tested giving the hormone FSH (called Ovagen) to dairy cows soon after they gave birth. It showed that FSH made more eggs available for collection, but it didn’t change how many cows got pregnant later. The repeated egg‑collection procedures didn’t hurt later fertility.

pubmed Oct 15, 2021

Towards better process management in wastewater treatment plants: Process analytics based on SHAP values for tree-based machine learning methods.

Wang. Dong D; Thunéll. Sven S; Lindberg. Ulrika U; Jiang. Lili L; Trygg. Johan J; Tysklind. Mat...

The paper talks about using machine‑learning models and SHAP explanations to understand how wastewater plants clean water. It doesn’t discuss the peptide ovagen or any health‑related effects, so it isn’t useful for biohackers looking for longevity or performance tips.

pubmed May 8, 2019

Does comprehensive geriatric assessment (CGA) in an outpatient care setting affect the causes of death and the quality of palliative care? A subanalysis of the age-FIT study.

Dahlqvist. Jenny J; Ekdahl. Anne A; Friedrichsen. Maria M

A study looked at whether a detailed health check for older adults (called comprehensive geriatric assessment) changed why they died or improved end‑of‑life care. It found no difference in death causes, but the group that got the assessment received more help from specialist palliative teams, though overall care quality didn’t improve.

pubmed Mar 26, 2010

Effects of low-dose follicle-stimulating hormone administration on follicular dynamics and preovulatory follicle characteristics in dairy cows during the summer.

Friedman. E E; Glick. G G; Lavon. Y Y; Roth. Z Z

This study looked at giving tiny amounts of a hormone called FSH (sold as Ovagen) to dairy cows during hot weather to see if it helps their ovaries make better eggs. The researchers found that low doses can boost the number of developing follicles, but the benefits to the final egg‑producing follicle were small and the results are specific to cows, not people.

pubmed 2001

Procedure for successful interspecific embryo transfer from mouflon (Ovis gmelini musimon) to Spanish Merino sheep (Ovis aries).

Santiago-Moreno. J J; González-Bulnes. A A; Gómez-Brunet. A A; Cocero. M J MJ; del Campo....

The study used a peptide called Ovagen to boost egg production in wild sheep and then moved those embryos into domestic sheep, resulting in a few successful pregnancies. This is a livestock breeding technique and doesn’t give any direct advice or benefits for human health or performance.

pubmed 2003

Influence of maternal environment on the number of transferable embryos obtained in response to superovulatory FSH treatments in ewes.

González-Bulnes. Antonio A; García-García. Rosa María RM; Castellanos. Vanesa V;...

Researchers gave a peptide called Ovagen to sheep to try to increase the number of embryos. They found that embryo success was linked to the number of small follicles present before treatment and to hormone patterns, and that embryos taken from the oviduct were healthier than those from the uterus. This work is specific to sheep reproduction and doesn’t give usable advice for human health or performance.